GSK plc held its 26th hybrid Annual General Meeting on May 6, 2026, where all 25 resolutions passed with strong shareholder support representing approximately 76% of issued share capital.
Key takeaways
All 25 AGM resolutions passed on poll, with votes for ranging from 93.98% to 99.94% of total votes cast.
76.59% of issued share capital (4,054,826,603 shares) participated via votes cast and withheld.
Election of new director Luke Miels approved with 3,081,325,569 votes for (99.37% of cast).
Re-elections of all directors, including Sir Jonathan Symonds and Julie Brown, received overwhelming support.
Special resolutions, including share buyback authority and amended Articles, passed despite higher opposition.
Higher participation than 2025 AGM (76.59% vs 74.21%).